NGD Infection Prevention

NGD Infection Prevention is a diagnostics and health technology company that provides a fully automated, end-to-end whole-genome sequencing (WGS) platform for real-time infection transmission detection in hospitals. Spun off from Next Gen Diagnostics in early 2026, the company utilizes its proprietary NGD200 system and EpiAssist bioinformatics pipeline to identify and track the spread of bacterial pathogens, including antibiotic-resistant strains. By delivering actionable reports overnight, the platform enables healthcare providers to intervene quickly, reducing hospital-acquired infections, patient length-of-stay, and associated mortality. The company's technology automates both frontend sample preparation and backend bioinformatic analysis, making high-resolution genomic surveillance practical and cost-effective for broad clinical adoption. NGD Infection Prevention operates facilities in Massachusetts and Israel and is focused on scaling its technology across thousands of hospitals, nursing homes, and dialysis centers globally.